Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Each vial is verified to 99.0% purity and shipped with a certificate of analysis tied to the unique vial code printed on the label
Reporting helps build the evidence base around the real-world safety of such compounds and supports MHRA regulatory activity
Sechi, L
This proactive approach sets the foundation for lasting success
Regulatory watch Last reviewed Jul 1, 2026 Next review Jul 29, 2026 Evidence snapshot AOD-9604 was developed by Metabolic Pharmaceuticals (Australia) as a modified C-terminal fragment (residues 177-191) of human growth hormone, designed to retain lipolytic activity without growth-promoting effects
US$ 24.87
US$ 29.63
US$ 26.05
